LogicBio Therapeutics (LOGC) Misses Q1 EPS by 27c
Tweet
Share
E-mailGet Alerts LOGC Hot Sheet
Price: $7.06 --0%
EPS Growth %: +82.6%
Financial Fact:
Tax provision: 0
Today's EPS Names:
MAYS, CRMT, REPL, More
EPS Growth %: +82.6%
Financial Fact:
Tax provision: 0
Today's EPS Names:
MAYS, CRMT, REPL, More
Join SI Premium – FREE
LogicBio Therapeutics (NASDAQ: LOGC) reported Q1 EPS of ($0.27).
For earnings history and earnings-related data on LogicBio Therapeutics (LOGC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Synopsys upgraded at Piper Sandler on Intel foundry momentum, Apple opportunity
- BMO Capital on Pfizer (PFE): 'SigVie Trial Misses on OS With Signs of Benefit for Future Trials'
- Canaf Reports Financial Results for Q2 2026 and Progress on Self-Storage Platform
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
